Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 831603, 17 pages
http://dx.doi.org/10.1155/2014/831603
Review Article

Treatment Comparison in Rheumatoid Arthritis: Head-to-Head Trials and Innovative Study Designs

1Department of Rheumatology, Gaetano Pini Institute Via Gaetano Pini 9, 20121 Milano, Italy
2Division of Rheumatology, University of Pavia, IRCCS Policlinico San Matteo Foundation, Piazzale Golgi 2, 27100 Pavia, Italy

Received 22 January 2014; Accepted 15 March 2014; Published 16 April 2014

Academic Editor: Lorenzo Cavagna

Copyright © 2014 Ennio Giulio Favalli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [7 citations]

The following is the list of published articles that have cited the current article.

  • A. Turrión Nieves, R. Martín Holguera, A. Sánchez Atrio, M.L. Romero Bogado, and M. Álvarez de Mon Soto, “Tratamientos biológicos en enfermedades reumatológicas y autoinmunes sistémicas,” Medicine - Programa de Formación Médica Continuada Acreditado, vol. 11, no. 92, pp. 5496–5509, 2015. View at Publisher · View at Google Scholar
  • Ennio Giulio Favalli, Andrea Becciolini, and Martina Biggioggero, “The role of methotrexate as combination therapy with etanercept in rheumatoid arthritis: Retrospective analysis of a local registry,” Journal of International Medical Research, vol. 44, no. 1, pp. 113–118, 2016. View at Publisher · View at Google Scholar
  • R Fleischmann, R Landewé, and J Smolen, “Review of head-to-head study designs in rheumatoid arthritis,” Seminars in Arthritis and Rheumatism, 2016. View at Publisher · View at Google Scholar
  • Livio Garattini, Francesca Ghislandi, and Anna Padula, “ Older anti-TNF- α agents: why not group them for common indications in the EU? ,” Expert Review of Pharmacoeconomics & Outcomes Research, pp. 1–4, 2016. View at Publisher · View at Google Scholar
  • Anat Fisher, Ken Bassett, Gautam Goel, Dana Stanely, M. Alan Brookhart, Hugh R. Freeman, James M. Wright, and Colin R. Dormuth, “Heterogeneity in Comparisons of Discontinuation of Tumor Necrosis Factor Antagonists in Rheumatoid Arthritis - A Meta-Analysis,” Plos One, vol. 11, no. 12, pp. e0168005, 2016. View at Publisher · View at Google Scholar
  • Sara Monti, Catherine Klersy, Roberto Gorla, Piercarlo Sarzi-Puttini, Fabiola Atzeni, Raffaele Pellerito, Enrico Fusaro, Giuseppe Paolazzi, Pier Andrea Rocchetta, Ennio Giulio Favalli, Antonio Marchesoni, and Roberto Caporali, “Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry,” Clinical Rheumatology, vol. 36, no. 4, pp. 753–761, 2017. View at Publisher · View at Google Scholar
  • Sara Monti, Vittorio Grosso, Monica Todoerti, and Roberto Caporali, “Randomized controlled trials and real-world data: differences and similarities to untangle literature data,” Rheumatology, vol. 57, no. Supplement_7, pp. vii54–vii58, 2018. View at Publisher · View at Google Scholar